Page 290 - EJMO-9-2

Eurasian Journal of
Medicine and Oncology QGJSF multi-target mechanisms in osteoporosis

skeletal development and bone homeostasis by regulating doi: 10.1038/s41419-020-2238-1
osteogenesis. Nat Commun. 2021;12(1):6891.
35. Zauli G, Rimondi E, Corallini F, Fadda R, Capitani S,
doi: 10.1038/s41467-021-27273-w Secchiero P. MDM2 antagonist nutlin-3 suppresses the
proliferation and differentiation of human pre-osteoclasts
25. Joung YH, Darvin P, Kang DY, et al. Methylsulfonylmethane
Inhibits RANKL-induced osteoclastogenesis in BMMs through a p53-dependent pathway. J Bone Miner Res.
by suppressing NF-κB and STAT3 activities. PLoS One. 2007;22(10):1621-1630.
2016;11(7):e0159891. doi: 10.1359/jbmr.070618
doi: 10.1371/journal.pone.0159891 36. Tong X, Gu J, Chen M, et al. P53 positively regulates
26. Zhang B, Qu Z, Hui H, et al. Exploring the therapeutic osteoprotegerin-mediated inhibition of osteoclastogenesis
potential of isoorientin in the treatment of osteoporosis: by downregulating TSC2-induced autophagy in vitro.
A study using network pharmacology and experimental Differentiation. 2020;114:58-66.
validation. Mol Med. 2024;30(1):27. doi: 10.1016/j.diff.2020.06.002
doi: 10.1186/s10020-024-00799-7 37. Qu L, Zhao M, Wang D, Song L, Zhou K. Research progress
27. Chen X, Chen W, Aung ZM, Han W, Zhang Y, Chai G. and mechanism of estrogen receptor α in postmenopausal
LY3023414 inhibits both osteogenesis and osteoclastogenesis osteoporosis. Chin J Osteoporos. 2024;30(7):1021-1027.
through the PI3K/Akt/GSK3 signalling pathway. Bone Joint 38. Feng C, Xu Z, Tang X, Cao H, Zhang G, Tan J. Estrogen-
Res. 2021;10(4):237-249. related receptor α: A significant regulator and promising
doi: 10.1302/2046-3758.104.BJR-2020-0255.R2 target in bone homeostasis and bone metastasis. Molecules.
2022;27(13):3976.
28. Kawamura N, Kugimiya F, Oshima Y, et al. Akt1 in
osteoblasts and osteoclasts controls bone remodeling. PLoS doi: 10.3390/molecules27133976
One. 2007;2(10):e1058. 39. Moon YJ, Zhang Z, Bang IH, et al. Sirtuin 6 in preosteoclasts
doi: 10.1371/journal.pone.0001058 suppresses age- and estrogen deficiency-related bone
loss by stabilizing estrogen receptor α. Cell Death Differ.
29. Vaddavalli PL, Schumacher B. The p53 network: Cellular
and systemic DNA damage responses in cancer and aging. 2019;26(11):2358-2370.
Trends Genet. 2022;38(6):598-612. doi: 10.1038/s41418-019-0306-9
doi: 10.1016/j.tig.2022.02.010 40. Kim SJ, Piao Y, Lee MG, et al. Loss of sirtuin 6 in osteoblast
30. Wang B, Wang J. Research progress on MDM2/MDMX lineage cells activates osteoclasts, resulting in osteopenia.
heterodimer and MDMX phosphorylation in regulating Bone. 2020;138:115497.
p53. Chin Bull Life Sci. 2020;32(5):446-452. doi: 10.1016/j.bone.2020.115497
doi: 10.13376/j.cbls/2020056 41. Melville KM, Kelly NH, Surita G, et al. Effects of deletion of
31. Hojo H, Ohba S, He X, Lai LP, McMahon AP. Sp7/osterix ERα in osteoblast-lineage cells on bone mass and adaptation
is restricted to bone-forming vertebrates where it acts to mechanical loading differ in female and male mice. J Bone
as a dlx co-factor in osteoblast specification. Dev Cell. Miner Res. 2015;30(8):1468-1480.
2016;37(3):238-253. doi: 10.1002/jbmr.2488
doi: 10.1016/j.devcel.2016.04.002 42. Yang Y, Feng N, Liang L, et al. Progranulin, a moderator
32. Kawane T, Komori H, Liu W, et al. Dlx5 and mef2 regulate of estrogen/estrogen receptor α binding, regulates bone
a novel runx2 enhancer for osteoblast-specific expression. homeostasis through PERK/p-eIF2 signaling pathway. J Mol
J Bone Miner Res. 2014;29(9):1960-1969. Med (Berl). 2022;100(8):1191-1207.
doi: 10.1002/jbmr.2240 doi: 10.1007/s00109-022-02233-z
33. Zhen YF, Wang GD, Zhu LQ, et al. P53 dependent 43. León-Reyes G, Argoty-Pantoja AD, Becerra-Cervera A,
mitochondrial permeability transition pore opening is López-Montoya P, Rivera-Paredez B, Velázquez-Cruz R.
required for dexamethasone-induced death of osteoblasts. Oxidative-stress-related genes in osteoporosis: A systematic
J Cell Physiol. 2014;229(10):1475-1483. review. Antioxidants (Basel). 2023;12(4):915.
doi: 10.1002/jcp.24589 doi: 10.3390/antiox12040915
34. Zhang F, Peng W, Zhang J, et al. P53 and Parkin co-regulate 44. Knowles HJ, Cleton-Jansen AM, Korsching E,
mitophagy in bone marrow mesenchymal stem cells to Athanasou NA. Hypoxia-inducible factor regulates
promote the repair of early steroid-induced osteonecrosis of osteoclast-mediated bone resorption: Role of angiopoietin-
the femoral head. Cell Death Dis. 2020;11(1):42. like 4. FASEB J. 2010;24(12):4648-4659.

Volume 9 Issue 2 (2025) 282 doi: 10.36922/EJMO025150103